Skip to main content

Table 1 Inclusion/exclusion criteria

From: Multipoint Pacing versus conventional ICD in Patients with a Narrow QRS complex (MPP Narrow QRS trial): study protocol for a pilot randomized controlled trial

A. Inclusion criteria

HF with NYHA class II/III

LVEF < 35% in patients on OPT for at least 3 months and candidate for ICD

Patients with left ventricular contractile reserve at low-dose dobutamine stress echocardiography test

QRS duration: 100–130 ms

Ability and willingness to comply with study requirements

Successful quadripolar LV lead implantation (only for treatment group)

B. Exclusion criteria

Myocardial infarction, unstable angina within 40 days prior to enrollment

Cardiac revascularization (PTCA, stent or CABG) in the 4 weeks prior to enrollment or planned for the 3 months following enrollment

Cerebrovascular accident (CVA) or transient ischemic attack (TIA) in the 3 months prior to enrollment

Primary valvular disease

Inability to comply with the follow-up schedule

Age less than 18 years

Pregnancy or intention to become pregnant during the period of the investigation

Classification of status 1 for cardiac transplantation or consideration for transplantation over the next 12 months

Previous cardiac transplantation

Life expectancy < 12 months

Permanent atrial fibrillation

  1. HF heart failure, NYHA New York Heart Association, LVEF left ventricular ejection fraction, OPT optimized therapy, ICD implantable cardioverter defibrillator, LV left ventricle, PTCA percutaneous transluminal coronary angioplasty, CABG coronary artery bypass graft surgery